Spanish Red Biotech Pipeline

MSD

Mavezelimab/Pembrolizumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: 4 Select Advanced Solid Tumors
Phase: 1Phase I in Spain